Recruitment

Recruitment Status
Active, not recruiting
Estimated Enrollment
100

Summary

Conditions
  • Bone
  • CNS-Spinal CD/MEMBR, NOS
  • Lymph Nodes
  • Melanoma
  • Ovarian Cancer
  • Sarcoma
  • Soft Tissue
Type
Interventional
Phase
Phase 3
Design
Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Treatment

Participation Requirements

Age
Between 18 years and 125 years
Gender
Both males and females

Description

Not Provided

Not Provided

Tracking Information

NCT #
NCT01223248
Collaborators
  • University of Pisa
  • University of California, San Francisco
  • The Champalimaud Centre, Lisbon, Portugal
Investigators
Principal Investigator: Michael Zelefsky, MD Memorial Sloan Kettering Cancer Center